low molecular weight factor(s)
LOW MOLECULAR WEIGHT RHEUMATOID FACTOR
10
Low molecular weight S nitrosothiols and blood vessel injury
5
Low Molecular Weight Heparin as A Therapeutic Tool for Cancer; Special Emphasis on Breast Cancer
8
Further insight into the heparin-releasable and glycosylphosphatidylinositol-lipid—anchored forms of tissue factor pathway inhibitor
12
Inhibition of Amyloidosis Using Low-Molecular-Weight Heparins
6
Fibroblast growth factor 2 regulates human cardiac myofibroblast mediated extracellular matrix remodeling
11
Motility and Adhesiveness in Human Neutrophils: EFFECTS OF CHEMOTACTIC FACTORS
10
Daily administration of low molecular weight heparin increases Hepatocyte Growth Factor serum levels in gynaecological patients: pharmacokinetic parameters and clinical implications
8
Arterial indications for the low molecular weight heparins
7
Ordered polyesters and polyester-sulfones: aromatic nucleophilic substitution reactions involving diaryl ethers
213
Recurrent Implantation Failure and Low Molecular Weight Heparin
17
Targeted Systems in Cancer Treatment
12
Low molecular weight heparins in the treatment of venous thromboembolism
5
Structural determinants in a library of low molecular weight gelators
19
Influx of kininogens into nasal secretions after antigen challenge of allergic individuals
8
Survival of 125iodine labeled Factor VIII in normals and patients with classic hemophilia Observations on the heterogeneity of human Factor VIII
13
Immunologic Specificity of Transfer Factor
5
Molecular fingerprinting of particulate organic matter as a new tool for its source apportionment: changes along a headwater drainage in coarse, medium and fine particles as a function of rainfalls
13
Vol 43, No 1 (2013)
7
Low molecular weight chitosan nanoparticulate system at low N:P ratio for nontoxic polynucleotide delivery
16